Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Key Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Secondary Sources
2.1.1.2 Key Data from Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Primary Sources
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Approach 1: Company Revenue Estimation Approach
2.2.1.2 Approach 2: Presentations of Companies and Primary Interviews
2.2.1.3 Growth Forecast
2.2.1.4 CAGR Projections
2.2.2 Top-Down Approach
2.3 Market Breakdown & Data Triangulation
2.4 Market Share Assessment
2.5 Research Assumptions
2.5.1 Parametric Assumptions
2.6 Research Limitations
2.7 Risk Assessment

4.1 Autoimmunity Diagnostics Market Overview
4.2 Autoimmunity Diagnostics Market, by Product, 2025 vs. 2031
4.3 Autoimmunity Diagnostics Market, by Test Type, 2025 vs. 2031
4.4 Autoimmunity Diagnostics Market, by Disease Type, 2025 vs. 2031
4.5 Autoimmunity Diagnostics Market, by End-user, 2025 vs. 2031
4.6 Autoimmunity Diagnostics Market: Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence of Autoimmune Diseases
5.2.1.2 Rising Awareness Related to Early Disease Diagnosis
5.2.1.3 Increasing Number of R&D Activities for Innovative Diagnostic Solutions
5.2.1.4 Advancements in Diagnostic Technologies
5.2.2 Restraints
5.2.2.1 High Capital Requirements
5.2.3 Opportunities
5.2.3.1 Utilization of Biosensors for Autoimmune Disease Diagnosis
5.2.3.2 Growth Potential of Emerging Economies
5.2.3.3 Growing Number of Reagent Rental Agreements
5.2.4 Challenges
5.2.4.1 Complexities Associated with Diagnosis of Autoimmune Diseases
5.2.4.2 Shortage of Skilled Professionals
5.3 Pricing Analysis
5.3.1 Indicative Selling Price Trend, by Product, 2023-2025
5.3.2 Indicative Selling Price Trend of Assays, by Key Player, 2023-2025
5.3.3 Indicative Selling Price Trend of Autoimmunity Diagnostics Products, by Region, 2023-2025
5.4 Patent Analysis
5.4.1 List of Major Patents
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Trade Analysis
5.7.1 Import Data (HS Code 3822)
5.7.2 Export Data (HS Code 3822)
5.8 Ecosystem Analysis
5.8.1 Role in Ecosystem
5.9 Porter's Five Forces Analysis
5.9.1 Threat of New Entrants
5.9.2 Threat of Substitutes
5.9.3 Bargaining Power of Buyers
5.9.4 Bargaining Power of Suppliers
5.9.5 Intensity of Competitive Rivalry
5.10 Key Stakeholders & Buying Criteria
5.10.1 Key Stakeholders in Buying Process
5.10.2 Buying Criteria
5.10.3 Regulatory Landscape
5.10.3.1 North America
5.10.3.1.1 US
5.10.3.1.2 Canada
5.10.3.2 Europe
5.10.3.2.1 Germany
5.10.3.2.2 UK
5.10.3.2.3 France
5.10.3.2.4 Italy
5.10.3.3 Asia-Pacific
5.10.3.3.1 China
5.10.3.3.2 Japan
5.10.3.3.3 India
5.10.3.3.4 Australia
5.10.3.4 Latin America
5.10.3.5 Middle East
5.10.3.5.1 Africa
5.10.4 Regulatory Bodies, Government Agencies, and Other Organizations
5.11 Technology Analysis
5.11.1 Key Technologies
5.11.1.1 Immunoassays
5.11.2 Complementary Technologies
5.11.2.1 Flow Cytometry
5.12 Key Conferences & Events, 2025-2026
5.13 Trends/Disruptions Impacting Customers’ Businesses
5.14 Investment & Funding Scenario
5.15 Case Study Analysis
5.15.1 Case Study 1: Laboratory-based Diagnosis of Systemic Lupus Erythematosus
5.15.2 Case Study 2: Diagnostic Importance of Autoantibody Testing in Identification of Latent Autoimmune Diabetes in Adults (Lada)
5.16 Impact of AI/Generative AI on Autoimmunity Diagnostics Market
5.16.1 Introduction
5.16.2 Market Potential of AI
5.16.3 AI Use Cases
5.16.4 Implementation of AI, by Key Company and Case
5.16.5 Future of AI in Autoimmunity Diagnostics Market
5.17 Trump Tariff Impact on Autoimmunity Diagnostics Market
5.17.1 Introduction
5.17.2 Key Tariff Rates
5.17.3 Price Impact Analysis
5.17.4 Key Impact on Country/Region
5.17.4.1 North America
5.17.4.2 Europe
5.17.4.3 Asia-Pacific
5.17.5 Impact on End-use Industries
5.17.5.1 Clinical Laboratories
5.17.5.2 Hospitals & Clinics

6.1 Introduction
6.2 Consumables
6.2.1 Recurring Purchase for High Volume of Diagnostic Testing to Propel Market
6.3 Instruments
6.3.1 Growing Need for Automation and High-Throughput Testing to Drive Market

7.1 Introduction
7.2 Autoantibodies and Immunologic Tests
7.2.1 Accurate Detection & Monitoring Abilities for Broad Applications to Propel Market
7.3 Routine Laboratory Tests
7.3.1 Recurrent Testing due to Cost Efficiency to Boost Demand
7.4 Inflammatory Tests
7.4.1 Ability of Inflammatory Markers to Detect Abnormalities to Drive Market
7.5 Urinalysis Tests
7.5.1 Technological Advancements in Urine Analyzers to Fuel Uptake
7.6 Other Tests

8.1 Introduction
8.2 Systemic Autoimmune Diseases
8.2.1 Rheumatoid Arthritis
8.2.1.1 Uptake of Rheumatoid Factor Immunological Test to Boost Demand
8.2.2 Systemic Lupus Erythematosus
8.2.2.1 Utilization of Autoimmune Testing Kits for Constant Monitoring to Propel Market
8.2.3 Psoriasis
8.2.3.1 Frequent Association with Systemic Inflammation and Comorbidities to Boost Demand
8.2.4 Multiple Sclerosis
8.2.4.1 Public-Private Investments for Ms Awareness to Fuel Market
8.2.5 Other Systemic Autoimmune Diseases
8.3 Organ-Specific Autoimmune Diseases
8.3.1 Type-1 Diabetes
8.3.1.1 Rising Global Incidence Among Children & Adults to Fuel Market
8.3.2 Celiac Disease
8.3.2.1 Growing Awareness Regarding Gluten Sensitivity and Improved Testing Availability to Drive Market
8.3.3 Inflammatory Bowel Disease
8.3.3.1 Growing Awareness of Chronic Gastrointestinal Autoimmune Disorders to Fuel Market
8.3.4 Other Organ-Specific Autoimmune Diseases

9.1 Introduction
9.2 Clinical Laboratories
9.2.1 Ability to Conduct High Volume of Specialized Tests to Propel Market
9.3 Hospitals & Clinics
9.3.1 Growing Awareness of Early Disease Diagnosis to Fuel Uptake
9.4 Other End-users

10.1 Introduction
10.2 North America
10.2.1 North America: Macroeconomic Outlook
10.2.2 US
10.2.2.1 High Healthcare Expenditure and Expansive Research Initiatives for Product Commercialization to Boost Demand
10.2.3 Canada
10.2.3.1 Rising Prevalence of Chronic Autoimmune Conditions to Drive Market
10.3 Europe
10.3.1 Europe: Macroeconomic Outlook
10.3.2 UK
10.3.2.1 Growing R&D Efforts for Early Disease Diagnosis to Fuel Uptake
10.3.3 Germany
10.3.3.1 Increasing Incidence of Multiple Sclerosis to Drive Market
10.3.4 France
10.3.4.1 Expansion of Lab Modernization to Support Market Growth
10.3.5 Italy
10.3.5.1 Growing Disease Burden and Aging Demographics to Fuel Market
10.3.6 Spain
10.3.6.1 Prevalence of Celiac Disease to Drive Market
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Asia-Pacific: Macroeconomic Outlook
10.4.2 China
10.4.2.1 Government Initiatives for Early Autoimmune Disease Screening to Fuel Market
10.4.3 Japan
10.4.3.1 Rapidly Aging Population and Advanced Healthcare Infrastructure to Boost Demand
10.4.4 India
10.4.4.1 Government-Led Healthcare Initiatives and Rapid Expansion of Diagnostic Infrastructure to Propel Market
10.4.5 Australia
10.4.5.1 Increasing Incidences of Autoimmune Diseases to Support Market Growth
10.4.6 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Increasing Incidence of Type-1 Diabetes to Fuel Market
10.5.2 Latin America: Macroeconomic Outlook
10.6 Middle East & Africa
10.6.1 Favorable Government Initiatives for Early Disease Diagnosis to Support Market Growth
10.6.2 Middle East & Africa: Macroeconomic Outlook

11.1 Introduction
11.2 Key Player Strategy/Right to Win
11.2.1 Overview of Strategies Adopted by Players in Autoimmunity Diagnostics Market
11.3 Revenue Analysis, 2022-2024
11.4 Market Share Analysis, 2024
11.5 Company Evaluation Matrix: Key Players, 2024
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Company Footprint: Key Players, 2024
11.5.5.1 Company Footprint
11.5.5.2 Region Footprint
11.5.5.3 Product Footprint
11.5.5.4 Test Type Footprint
11.5.5.5 Disease Type Footprint
11.6 Company Evaluation Matrix: Startups/SMEs, 2024
11.6.1 Progressive Companies
11.6.2 Responsive Companies
11.6.3 Dynamic Companies
11.6.4 Starting Blocks
11.6.5 Company Evaluation Matrix: Startups/SMEs, 2024
11.6.5.1 Detailed List of Key Startups/SMEs
11.6.5.2 Competitive Benchmarking of Startups/SMEs
11.7 Company Valuation & Financial Metrics
11.7.1 Financial Metrics
11.7.2 Company Valuation
11.8 Brand/Product Comparison
11.9 Competitive Scenario
11.9.1 Product Launches & Approvals
11.9.2 Deals
11.9.3 Expansions
11.9.4 Other Developments

12.1 Key Players
12.1.1 F. Hoffmann-La Roche Ltd.
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Analyst's View
12.1.1.3.1 Key Strengths
12.1.1.3.2 Strategic Choices
12.1.1.3.3 Weaknesses & Competitive Threats
12.1.2 Abbott Laboratories
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Analyst's View
12.1.2.3.1 Key Strengths
12.1.2.3.2 Strategic Choices
12.1.2.3.3 Weaknesses & Competitive Threats
12.1.3 Revvity, Inc.
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Product Launches
12.1.3.4 Analyst's View
12.1.3.4.1 Key Strengths
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses & Competitive Threats
12.1.4 Thermo Fisher Scientific Inc.
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Product Launches
12.1.4.3.2 Deals
12.1.4.3.3 Other Developments
12.1.4.4 Analyst's View
12.1.4.4.1 Key Strengths
12.1.4.4.2 Strategic Choices
12.1.4.4.3 Weaknesses & Competitive Threats
12.1.5 Siemens Healthineers AG
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Product Approvals
12.1.5.3.2 Deals
12.1.5.4 Analyst's View
12.1.5.4.1 Key Strengths
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses & Competitive Threats
12.1.6 Bio-Rad Laboratories, Inc.
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.7 Grifols SA
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.7.3 Recent Developments
12.1.7.3.1 Deals
12.1.8 Werfen SA
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.8.3 Recent Developments
12.1.8.3.1 Product Approvals
12.1.9 Exagen Inc.
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Product Launches
12.1.9.3.2 Deals
12.1.10 Trinity Biotech PLC
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.11 Tecan Group Ltd.
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.12 Danaher Corporation
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.12.3 Recent Developments
12.1.12.3.1 Deals
12.1.13 Biosynex SA
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.13.3 Recent Developments
12.1.13.3.1 Deals
12.1.14 Quidelortho Corporation
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.14.3 Recent Developments
12.1.14.3.1 Expansions
12.1.15 Biomérieux SA
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.1.16 Diasorin S.P.A.
12.1.16.1 Business Overview
12.1.16.2 Products Offered
12.1.16.3 Recent Developments
12.1.16.3.1 Deals
12.2 Other Players
12.2.1 Becton, Dickinson and Company
12.2.2 Sd Biosensor, Inc.
12.2.3 Cambridge Life Sciences Ltd.
12.2.4 A. Menarini Diagnostics S.R.L
12.2.5 Sebia
12.2.6 Kronus
12.2.7 Erba Group
12.2.8 Aesku.Group GmbH
12.2.9 Medsource Ozone Biomedicals Pvt. Ltd.
12.2.10 Epitope Diagnostics Inc.

13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Table 1 Autoimmunity Diagnostics Market: Key Data from Primary Sources
Table 2 Autoimmunity Diagnostics Market: Risk Assessment Analysis
Table 3 Nih-Funded Investments & Grants, by Disease Type
Table 4 A Few Recent Examples of Innovations in Autoimmune Diagnostic Technologies are Listed Below:
Table 5 Indicative Selling Pricing Trend of Autoimmunity Diagnostics Products, 2023-2025
Table 6 Indicative Selling Price Trend of Assays, by Key Player, 2023-2025
Table 7 Indicative Selling Price Trend of Autoimmunity Diagnostics Products, by Region, 2023-2025
Table 8 Autoimmunity Diagnostics Market: List of Major Patents, 2023-2024
Table 9 Import Data (HS Code 3822), by Country, 2020-2024 (USD Million)
Table 10 Export Data (HS Code 3822), by Country, 2020-2024 (USD Million)
Table 11 Autoimmunity Diagnostics Market: Role in Ecosystem
Table 12 Autoimmunity Diagnostics Market: Porter's Five Forces Analysis
Table 13 Influence of Stakeholders on Buying Process of Autoimmunity Diagnostics Products (%)
Table 14 Key Buying Criteria for Autoimmunity Diagnostics Products
Table 15 Classification of Ivd Devices in Europe
Table 16 Time, Cost, and Complexity of Registration Process in Japan
Table 17 North America: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Europe: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 19 Asia-Pacific: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 20 Latin America: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 21 Rest of the World: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 22 Autoimmunity Diagnostics Market: Detailed List of Key Conferences & Events, January 2025-December 2026
Table 23 US Adjusted Reciprocal Tariff Rates
Table 24 Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 25 Key Companies Offering Consumables
Table 26 Autoimmunity Diagnostics Market for Consumables, by Region, 2023-2031 (USD Million)
Table 27 North America: Autoimmunity Diagnostics Market for Consumables, by Country, 2023-2031 (USD Million)
Table 28 Europe: Autoimmunity Diagnostics Market for Consumables, by Country, 2023-2031 (USD Million)
Table 29 Asia-Pacific: Autoimmunity Diagnostics Market for Consumables, by Country, 2023-2031 (USD Million)
Table 30 Key Companies Offering Instruments
Table 31 Autoimmunity Diagnostics Market for Instruments, by Region, 2023-2031 (USD Million)
Table 32 North America: Autoimmunity Diagnostics Market for Instruments, by Country, 2023-2031 (USD Million)
Table 33 Europe: Autoimmunity Diagnostics Market for Instruments, by Country, 2023-2031 (USD Million)
Table 34 Asia-Pacific: Autoimmunity Diagnostics Market for Instruments, by Country, 2023-2031 (USD Million)
Table 35 Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 36 Autoimmunity Diagnostics Market for Autoantibodies and Immunologic Tests, by Region, 2023-2031 (USD Million)
Table 37 North America: Autoimmunity Diagnostics Market for Autoantibodies and Immunologic Tests, by Country, 2023-2031 (USD Million)
Table 38 Europe: Autoimmunity Diagnostics Market for Autoantibodies and Immunologic Tests, by Country, 2023-2031 (USD Million)
Table 39 Asia-Pacific: Autoimmunity Diagnostics Market for Autoantibodies and Immunologic Tests, by Country, 2023-2031 (USD Million)
Table 40 Autoimmunity Diagnostics Market for Routine Laboratory Tests, by Region, 2023-2031 (USD Million)
Table 41 North America: Autoimmunity Diagnostics Market for Routine Laboratory Tests, by Country, 2023-2031 (USD Million)
Table 42 Europe: Autoimmunity Diagnostics Market for Routine Laboratory Tests, by Country, 2023-2031 (USD Million)
Table 43 Asia-Pacific: Autoimmunity Diagnostics Market for Routine Laboratory Tests, by Country, 2023-2031 (USD Million)
Table 44 Autoimmunity Diagnostics Market for Inflammatory Tests, by Region, 2023-2031 (USD Million)
Table 45 North America: Autoimmunity Diagnostics Market for Inflammatory Tests, by Country, 2023-2031 (USD Million)
Table 46 Europe: Autoimmunity Diagnostics Market for Inflammatory Tests, by Country, 2023-2031 (USD Million)
Table 47 Asia-Pacific: Autoimmunity Diagnostics Market for Inflammatory Tests, by Country, 2023-2031 (USD Million)
Table 48 Autoimmunity Diagnostics Market for Urinalysis Tests, by Region, 2023-2031 (USD Million)
Table 49 North America: Autoimmunity Diagnostics Market for Urinalysis Tests, by Country, 2023-2031 (USD Million)
Table 50 Europe: Autoimmunity Diagnostics Market for Urinalysis Tests, by Country, 2023-2031 (USD Million)
Table 51 Asia-Pacific: Autoimmunity Diagnostics Market for Urinalysis Tests, by Country, 2023-2031 (USD Million)
Table 52 Autoimmunity Diagnostics Market for Other Tests, by Region, 2023-2031 (USD Million)
Table 53 North America: Autoimmunity Diagnostics Market for Other Tests, by Country, 2023-2031 (USD Million)
Table 54 Europe: Autoimmunity Diagnostics Market for Other Tests, by Country, 2023-2031 (USD Million)
Table 55 Asia-Pacific: Autoimmunity Diagnostics Market for Other Tests, by Country, 2023-2031 (USD Million)
Table 56 Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 57 Systemic Autoimmunity Diagnostics Market, by Type, 2023-2031 (USD Million)
Table 58 Systemic Autoimmunity Diagnostics Market, by Region, 2023-2031 (USD Million)
Table 59 North America: Systemic Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 60 Europe: Systemic Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 61 Asia-Pacific: Systemic Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 62 Key Companies Currently Offering Rheumatoid Arthritis Products
Table 63 Autoimmunity Diagnostics Market for Rheumatoid Arthritis, by Region, 2023-2031 (USD Million)
Table 64 North America: Autoimmunity Diagnostics Market for Rheumatoid Arthritis, by Country, 2023-2031 (USD Million)
Table 65 Europe: Autoimmunity Diagnostics Market for Rheumatoid Arthritis, by Country, 2023-2031 (USD Million)
Table 66 Asia-Pacific: Autoimmunity Diagnostics Market for Rheumatoid Arthritis, by Country, 2023-2031 (USD Million)
Table 67 Key Companies Currently Offering Systemic Lupus Erythematosus Products
Table 68 Autoimmunity Diagnostics Market for Systemic Lupus Erythematosus, by Region, 2023-2031 (USD Million)
Table 69 North America: Autoimmunity Diagnostics Market for Systemic Lupus Erythematosus, by Country, 2023-2031 (USD Million)
Table 70 Europe: Autoimmunity Diagnostics Market for Systemic Lupus Erythematosus, by Country, 2023-2031 (USD Million)
Table 71 Asia-Pacific: Autoimmunity Diagnostics Market for Systemic Lupus Erythematosus, by Country, 2023-2031 (USD Million)
Table 72 Autoimmunity Diagnostics Market for Psoriasis, by Region, 2023-2031 (USD Million)
Table 73 North America: Autoimmunity Diagnostics Market for Psoriasis, by Country, 2023-2031 (USD Million)
Table 74 Europe: Autoimmunity Diagnostics Market for Psoriasis, by Country, 2023-2031 (USD Million)
Table 75 Asia-Pacific: Autoimmunity Diagnostics Market for Psoriasis, by Country, 2023-2031 (USD Million)
Table 76 Key Companies Currently Offering Multiple Sclerosis Products
Table 77 Autoimmunity Diagnostics Market for Multiple Sclerosis, by Region, 2023-2031 (USD Million)
Table 78 North America: Autoimmunity Diagnostics Market for Multiple Sclerosis, by Country, 2023-2031 (USD Million)
Table 79 Europe: Autoimmunity Diagnostics Market for Multiple Sclerosis, by Country, 2023-2031 (USD Million)
Table 80 Asia-Pacific: Autoimmunity Diagnostics Market for Multiple Sclerosis, by Country, 2023-2031 (USD Million)
Table 81 Key Companies Currently Offering Other Systemic Autoimmune Disease Products
Table 82 Other Systemic Autoimmune Diseases Market, by Region, 2023-2031 (USD Million)
Table 83 North America: Other Systemic Autoimmune Diseases Market, by Country, 2023-2031 (USD Million)
Table 84 Europe: Other Systemic Autoimmune Diseases Market, by Country, 2023-2031 (USD Million)
Table 85 Asia-Pacific: Other Systemic Autoimmune Diseases Market, by Country, 2023-2031 (USD Million)
Table 86 Organ-Specific Autoimmunity Diagnostics Market, by Type, 2023-2031 (USD Million)
Table 87 Organ-Specific Autoimmunity Diagnostics Market, by Region, 2023-2031 (USD Million)
Table 88 North America: Organ-Specific Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 89 Europe: Organ-Specific Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 90 Asia-Pacific: Organ-Specific Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 91 Number of People Living with Type 1 Diabetes, 2024
Table 92 Key Companies Currently Offering Type 1 Diabetes Products
Table 93 Autoimmunity Diagnostics Market for Type 1 Diabetes, by Region, 2023-2031 (USD Million)
Table 94 North America: Autoimmunity Diagnostics Market for Type

Table 95 Europe: Autoimmunity Diagnostics Market for Type 1 Diabetes, by Country, 2023-2031 (USD Million)
Table 96 Asia-Pacific: Autoimmunity Diagnostics Market for Type 1 Diabetes, by Country, 2023-2031 (USD Million)
Table 97 Key Companies Offering Celiac Disease Products
Table 98 Autoimmunity Diagnostics Market for Celiac Disease, by Region, 2023-2031 (USD Million)
Table 99 North America: Autoimmunity Diagnostics Market for Celiac Disease, by Country, 2023-2031 (USD Million)
Table 100 Europe: Autoimmunity Diagnostics Market for Celiac Disease, by Country, 2023-2031 (USD Million)
Table 101 Asia-Pacific: Autoimmunity Diagnostics Market for Celiac Disease, by Country, 2023-2031 (USD Million)
Table 102 Key Companies Offering Inflammatory Bowel Disease Products
Table 103 Autoimmunity Diagnostics Market for Inflammatory Bowel Disease, by Region, 2023-2031 (USD Million)
Table 104 North America: Autoimmunity Diagnostics Market for Inflammatory Bowel Disease, by Country, 2023-2031 (USD Million)
Table 105 Europe: Autoimmunity Diagnostics Market for Inflammatory Bowel Disease, by Country, 2023-2031 (USD Million)
Table 106 Asia-Pacific: Autoimmunity Diagnostics Market for Inflammatory Bowel Disease, by Country, 2023-2031 (USD Million)
Table 107 Key Companies Currently Offering Other Organ-Specific Autoimmune Disease Products
Table 108 Other Organ-Specific Autoimmune Disease Diagnosis Market, by Region, 2023-2031 (USD Million)
Table 109 North America: Other Organ-Specific Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 110 Europe: Other Organ-Specific Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 111 Asia-Pacific: Other Organ-Specific Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 112 Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 113 Autoimmunity Diagnostics Market for Clinical Laboratories, by Region, 2023-2031 (USD Million)
Table 114 North America: Autoimmunity Diagnostics Market for Clinical Laboratories, by Country, 2023-2031 (USD Million)
Table 115 Europe: Autoimmunity Diagnostics Market for Clinical Laboratories, by Country, 2023-2031 (USD Million)
Table 116 Asia-Pacific: Autoimmunity Diagnostics Market for Clinical Laboratories, by Country, 2023-2031 (USD Million)
Table 117 Number of Hospitals, by Country, 2023
Table 118 Autoimmunity Diagnostics Market for Hospitals & Clinics, by Region, 2023-2031 (USD Million)
Table 119 North America: Autoimmunity Diagnostics Market for Hospitals & Clinics, by Country, 2023-2031 (USD Million)
Table 120 Europe: Autoimmunity Diagnostics Market for Hospitals & Clinics, by Country, 2023-2031 (USD Million)
Table 121 Asia-Pacific: Autoimmunity Diagnostics Market for Hospitals & Clinics, by Country, 2023-2031 (USD Million)
Table 122 Autoimmunity Diagnostics Market for Other End-users, by Region, 2023-2031 (USD Million)
Table 123 North America: Autoimmunity Diagnostics Market for Other End-users, by Country, 2023-2031 (USD Million)
Table 124 Europe: Autoimmunity Diagnostics Market for Other End-users, by Country, 2023-2031 (USD Million)
Table 125 Asia-Pacific: Autoimmunity Diagnostics Market for Other End-users, by Country, 2023-2031 (USD Million)
Table 126 Autoimmunity Diagnostics Maret, by Region, 2023-2031 (USD Million)
Table 127 North America: Macroeconomic Indicators
Table 128 North America: Number of Rheumatoid Arthritis (Ra) Cases, by Country, 2023-2031
Table 129 North America: Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 130 North America: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 131 North America: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 132 North America: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 133 North America: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 134 North America: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 135 North America: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 136 US: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 137 US: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 138 US: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 139 US: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 140 US: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 141 US: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 142 Canada: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 143 Canada: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 144 Canada: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 145 Canada: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 146 Canada: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 147 Canada: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 148 Europe: Macroeconomic Indicators
Table 149 Europe: Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 150 Europe: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 151 Europe: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 152 Europe: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 153 Europe: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 154 Europe: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 155 Europe: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 156 UK: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 157 UK: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 158 UK: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 159 UK: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 160 UK: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 161 UK: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 162 Germany: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 163 Germany: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 164 Germany: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 165 Germany: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 166 Germany: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 167 Germany: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 168 France: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 169 France: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 170 France: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 171 France: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 172 France: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 173 France: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 174 Italy: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 175 Italy: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 176 Italy: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 177 Italy: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 178 Italy: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 179 Italy: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 180 Spain: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 181 Spain: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 182 Spain: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 183 Spain: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 184 Spain: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 185 Spain: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 186 Rest of Europe: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 187 Rest of Europe: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 188 Rest of Europe: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 189 Rest of Europe: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 190 Rest of Europe: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 191 Rest of Europe: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 192 Asia-Pacific: Macroeconomic Indicators
Table 193 Asia-Pacific: Autoimmunity Diagnostics Market, by Country, 2023-2031 (USD Million)
Table 194 Asia-Pacific: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 195 Asia-Pacific: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 196 Asia-Pacific: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 197 Asia-Pacific: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 198 Asia-Pacific: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 199 Asia-Pacific: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 200 China: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 201 China: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 202 China: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 203 China: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 204 China: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 205 China: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 206 Japan: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 207 Japan: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 208 Japan: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 209 Japan: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 210 Japan: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 211 Japan: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 212 India: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 213 India: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 214 India: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 215 India: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 216 India: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 217 India: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 218 Australia: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 219 Australia: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 220 Australia: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 221 Australia: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 222 Australia: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 223 Australia: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 224 Rest of Asia-Pacific: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 225 Rest of Asia-Pacific: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 226 Rest of Asia-Pacific: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 227 Rest of Asia-Pacific: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 228 Rest of Asia-Pacific: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 229 Rest of Asia-Pacific: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 230 Latin America: Macroeconomic Indicators
Table 231 Latin America: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 232 Latin America: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 233 Latin America: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 234 Latin America: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 235 Latin America: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 236 Latin America: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 237 Middle East & Africa: Macroindicators
Table 238 Middle East & Africa: Autoimmunity Diagnostics Market, by Product, 2023-2031 (USD Million)
Table 239 Middle East & Africa: Autoimmunity Diagnostics Market, by Test Type, 2023-2031 (USD Million)
Table 240 Middle East & Africa: Autoimmunity Diagnostics Market, by Disease Type, 2023-2031 (USD Million)
Table 241 Middle East & Africa: Systemic Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 242 Middle East & Africa: Organ-Specific Autoimmune Diseases Market, by Type, 2023-2031 (USD Million)
Table 243 Middle East & Africa: Autoimmunity Diagnostics Market, by End-user, 2023-2031 (USD Million)
Table 244 Overview of Strategies Deployed by Key Players in Autoimmunity Diagnostics Market, January 2021-May 2025
Table 245 Autoimmunity Diagnostics Market: Degree of Competition
Table 246 Autoimmunity Diagnostics Market: Region Footprint
Table 247 Autoimmunity Diagnostics Market: Product Footprint
Table 248 Autoimmunity Diagnostics Market: Test Type Footprint
Table 249 Autoimmunity Diagnostics Market: Disease Type Footprint
Table 250 Autoimmunity Diagnostics Market: Detailed List of Key Startups/SMEs
Table 251 Autoimmunity Diagnostics Market: Competitive Benchmarking of Startups/SMEs, by Product and Disease Type
Table 252 Autoimmunity Diagnostics Market: Competitive Benchmarking of Startups/SMEs, by Region
Table 253 Autoimmunity Diagnostics Market: Product Launches & Approvals, January 2021-May 2025
Table 254 Autoimmunity Diagnostics Market: Deals, January 2021-May 2025
Table 255 Autoimmunity Diagnostics Market: Expansions, January 2021-May 2025
Table 256 Autoimmunity Diagnostics Market: Other Developments, January 2021-May 2025
Table 257 F. Hoffmann-La Roche Ltd.: Company Overview
Table 258 F. Hoffmann-La Roche Ltd.: Products Offered
Table 259 Abbott Laboratories: Company Overview
Table 260 Abbott Laboratories: Products Offered
Table 261 Revvity, Inc.: Company Overview
Table 262 Revvity, Inc.: Products Offered
Table 263 Revvity, Inc.: Product Launches, January 2021-May 2025
Table 264 Thermo Fisher Scientific Inc.: Company Overview
Table 265 Thermo Fisher Scientific Inc.: Products Offered
Table 266 Thermo Fisher Scientific Inc.: Product Launches, January 2021-May 2025
Table 267 Thermo Fisher Scientific Inc.: Deals, January 2021-May 2025
Table 268 Thermo Fisher Scientific Inc.: Other Developments, January 2021-May 2025
Table 269 Siemens Healthineers AG: Company Overview
Table 270 Siemens Healthineers AG: Products Offered
Table 271 Siemens Healthineers AG: Product Approvals, January 2021- May 2025
Table 272 Siemens Healthineers AG: Deals, January 2021- May 2025
Table 273 Bio-Rad Laboratories, Inc.: Company Overview
Table 274 Bio-Rad Laboratories, Inc.: Products Offered
Table 275 Grifols SA: Company Overview
Table 276 Grifols SA: Products Offered
Table 277 Grifols SA: Deals, January 2021- May 2025
Table 278 Werfen SA: Company Overview
Table 279 Werfen SA: Products Offered
Table 280 Werfen SA: Product Approvals, January 2021-May 2025
Table 281 Exagen Inc.: Company Overview
Table 282 Exagen Inc.: Products Offered
Table 283 Exagen Inc.: Product Launches, January 2021-May 2025
Table 284 Exagen Inc.: Deals, January 2021-May 2025
Table 285 Trinity Biotech PLC: Company Overview
Table 286 Trinity Biotech PLC: Products Offered
Table 287 Tecan Group Ltd.: Company Overview
Table 288 Tecan Group Ltd.: Products Offered
Table 289 Danaher Corporation: Company Overview
Table 290 Danaher Corporation: Products Offered
Table 291 Danaher Corporation: Deals, January 2021- May 2025
Table 292 Biosynex SA: Company Overview
Table 293 Biosynex SA: Products Offered
Table 294 Biosynex SA: Deals, January 2021- May 2025
Table 295 Quidelortho Corporation: Company Overview
Table 296 Quidelortho Corporation: Products Offered
Table 297 Quidelortho Corporation: Expansions, January 2021- May 2025
Table 298 Biomérieux SA: Company Overview
Table 299 Biomérieux SA: Products Offered
Table 300 Diasorin S.P.A.: Company Overview
Table 301 Diasorin S.P.A.: Products Offered
Table 302 Diasorin S.P.A.: Deals, January 2021- May 2025
Table 303 Becton, Dickinson and Company: Company Overview
Table 304 Sd Biosensor, Inc.: Company Overview
Table 305 Cambridge Life Sciences Ltd.: Company Overview
Table 306 A. Menarini Diagnostics S.R.L: Company Overview
Table 307 Sebia: Company Overview
Table 308 Kronus: Company Overview
Table 309 Erba Group: Company Overview
Table 310 Aesku.Group GmbH: Company Overview
Table 311 Medsource Ozone Biomedicals Pvt. Ltd.: Company Overview
Table 312 Epitope Diagnostics Inc.: Company Overview

Figure 1 Market Segmentation & Regional Scope
Figure 2 Autoimmunity Diagnostics Market: Research Design
Figure 3 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 4 Breakdown of Primaries
Figure 5 Bottom-Up Approach: Company Revenue Estimation Approach
Figure 6 CAGR Projections: Supply-Side Analysis
Figure 7 Autoimmunity Diagnostics Market: Top-Down Approach
Figure 8 Data Triangulation Methodology
Figure 9 Autoimmunity Diagnostics Market: Research Assumptions
Figure 10 Autoimmunity Diagnostics Market, by Product, 2025 vs. 2031 (USD Million)
Figure 11 Autoimmunity Diagnostics Market, by Test Type, 2025 vs. 2031 (USD Million)
Figure 12 Autoimmunity Diagnostics Market, by Disease Type, 2025 vs. 2031 (USD Million)
Figure 13 Autoimmunity Diagnostics Market, by End-user, 2025 vs. 2031 (USD Million)
Figure 14 Autoimmunity Diagnostics Market, by Region, 2025 vs. 2031 (USD Million)
Figure 15 Rising Prevalence of Autoimmune Diseases and Increasing Advancements in Diagnostic Technologies to Propel Market
Figure 16 Consumables Segment to Dominate Market During Forecast Period
Figure 17 Autoantibodies and Immunologic Tests Segment to Dominate Market During Forecast Period
Figure 18 Systemic Autoimmune Diseases Segment to Dominate Market During Forecast Period
Figure 19 Clinical Laboratories Segment to Dominate Market During Forecast Period
Figure 20 Asia-Pacific to Register Highest CAGR During Forecast Period
Figure 21 Autoimmunity Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Patent Analysis for Immunoassays (January 2014-December 2024)
Figure 23 Value Chain Analysis: Major Value Added During Manufacturing Assembly Phases
Figure 24 Autoimmunity Diagnostics Market: Supply Chain Analysis
Figure 25 Autoimmunity Diagnostics Market: Ecosystem Analysis
Figure 26 Autoimmunity Diagnostics Market: Porter's Five Forces Analysis
Figure 27 Influence of Stakeholders on Buying Process for Autoimmunity Diagnostics Products
Figure 28 Key Buying Criteria for Autoimmunity Diagnostics Products
Figure 29 Autoimmunity Diagnostics Market: Trends and Disruptions Impacting Customers’ Businesses
Figure 30 Number of Deals & Funding Activities in Autoimmunity Diagnostics Market
Figure 31 Market Potential of AI in Autoimmunity Diagnostics Market
Figure 32 North America: Autoimmunity Diagnostics Snapshot
Figure 33 Asia-Pacific: Autoimmunity Diagnostics Snapshot
Figure 34 Revenue Analysis of Key Players in Autoimmunity Diagnostics Market (2022-2024)
Figure 35 Market Share Analysis of Key Players in Autoimmunity Diagnostics Market (2024)
Figure 36 Autoimmunity Diagnostics Market: Company Evaluation Matrix (Key Players), 2024
Figure 37 Autoimmunity Diagnostics Market: Company Footprint
Figure 38 Autoimmunity Diagnostics Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 39 EV/EBITDA of Key Vendors
Figure 40 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 41 Autoimmunity Diagnostics Market: Brand Comparison for Instruments
Figure 42 F. Hoffmann-La Roche Ltd.: Company Snapshot (2024)
Figure 43 Abbott Laboratories: Company Snapshot (2024)
Figure 44 Revvity, Inc.: Company Snapshot (2024)
Figure 45 Thermo Fisher Scientific Inc.: Company Snapshot (2024)
Figure 46 Siemens Healthineers AG: Company Snapshot (2024)
Figure 47 Bio-Rad Laboratories, Inc.: Company Snapshot (2024)
Figure 48 Grifols SA: Company Snapshot (2024)
Figure 49 Werfen S.A: Company Snapshot (2024)
Figure 50 Exagen Inc.: Company Snapshot (2024)
Figure 51 Trinity Biotech PLC: Company Snapshot (2023)
Figure 52 Tecan Group Ltd.: Company Snapshot (2024)
Figure 53 Danaher Corporation: Company Snapshot (2024)
Figure 54 Biosynex SA: Company Snapshot (2024)
Figure 55 Quidelortho Corporation: Company Snapshot (2024)
Figure 56 Biomérieux SA: Company Snapshot (2024)
Figure 57 Diasorin S.P.A.: Company Snapshot (2024)